ReproCell Stock

ReproCell Book Value per Share

The Book Value per Share of ReproCell (4978.T) as of Sep 4, 2026 is 96.77 JPY. In the previous year, Book Value per Share was 89.51 JPY — a change of 8.10% (higher).

Book Value per Share

96.77JPY

YoY

8.10%

Last updated:

Book Value per Share of ReproCell is 2026 96.77 JPY. Book Value per Share of ReproCell was 2025 89.51 JPY. It decreases by 8.10% higher compared to the previous year.

The ReproCell Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Book Value per Share
Date
Book Value per Share
Jan 1, 2018
67.29 JPY
Jan 1, 2019
76.14 JPY
Jan 1, 2020
65.16 JPY
Jan 1, 2021
57.99 JPY
Jan 1, 2022
78.09 JPY
Jan 1, 2023
81.58 JPY
Jan 1, 2024
89.51 JPY
Jan 1, 2025
96.77 JPY
The ReproCell Book Value per Share history
YEARBook Value per ShareYoY
96.77JPY+8.10%
89.51JPY+9.72%
81.58JPY+4.47%
78.09JPY+34.66%
57.99JPY-11.01%
65.16JPY-14.42%
76.14JPY+13.15%
67.29JPY-15.20%
79.36JPY+1.39%
78.27JPY+2.58%
76.31JPY+36.38%
55.95JPY
Access this data via the Eulerpool API

ReproCell Stock analysis

What does ReproCell do? ReproCell, Inc. is a company that was founded in 2003 and specializes in the research and manufacture of cell cultures. The company is based in Yokohama, Japan and operates worldwide. Its business model includes providing services and products to support research and development activities in the field of regenerative medicine and cell therapy. The company is divided into three main divisions: the Biorepository Division, which provides human cells and tissues for research purposes; the Cell Manufacturing Division, which develops production processes for cell therapy products; and the Drug Discovery Division, which supports drug development through screening and in vitro testing. ReproCell offers a variety of cell cultures, including stem cells from various sources, as well as related media, reagents, and tools for cultivation and application. In addition, the company offers services in cell therapy production, working closely with customers to provide customized and high-quality therapies. ReproCell also supports drug and compound research through screening and in vitro testing, with various platforms available for the identification and evaluation of new compounds. The company has a history of growth and has become a leading player in the field of cell culture and cell therapy production. In conclusion, ReproCell plays a significant role in regenerative medicine and cell therapy production, offering a wide range of products and services to support research and development in these areas. It is poised to continue its growth and contribute to the development of new therapies in the future. ReproCell is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ReproCell stock

Book Value per Share of ReproCell is 96.77 JPY in 2026.

Book Value per Share of ReproCell changed from 89.51 JPY to 96.77 JPY, representing a 8.10% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Book Value per Share ReproCell since 2006 – with annual values, charts, and detailed analysis.

Book value per share represents the net asset value of the company per outstanding share. Comparing it to the stock price helps assess whether a stock is undervalued.

Access this data via the Eulerpool API

Balance Sheet — ReproCell

All Key Metrics — ReproCell